These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 22004671)
1. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs. Heltsley R; DePriest A; Black DL; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ J Anal Toxicol; 2011 Oct; 35(8):529-40. PubMed ID: 22004671 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid. Cone EJ; Clarke J; Tsanaclis L J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455 [TBL] [Abstract][Full Text] [Related]
3. Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens. Heltsley R; Depriest A; Black DL; Crouch DJ; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ J Anal Toxicol; 2012 Mar; 36(2):75-80. PubMed ID: 22337775 [TBL] [Abstract][Full Text] [Related]
4. Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry. Fritch D; Blum K; Nonnemacher S; Haggerty BJ; Sullivan MP; Cone EJ J Anal Toxicol; 2009; 33(9):569-77. PubMed ID: 20040131 [TBL] [Abstract][Full Text] [Related]
5. Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS. West R; Mikel C; Hofilena D; Guevara M Drug Alcohol Depend; 2018 Dec; 193():183-191. PubMed ID: 30391868 [TBL] [Abstract][Full Text] [Related]
6. Urine drug testing of chronic pain patients: licit and illicit drug patterns. Cone EJ; Caplan YH; Black DL; Robert T; Moser F J Anal Toxicol; 2008 Oct; 32(8):530-43. PubMed ID: 19007501 [TBL] [Abstract][Full Text] [Related]
7. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine. Vindenes V; Yttredal B; Oiestad EL; Waal H; Bernard JP; Mørland JG; Christophersen AS J Anal Toxicol; 2011 Jan; 35(1):32-9. PubMed ID: 21219701 [TBL] [Abstract][Full Text] [Related]
8. Drug testing and adherence monitoring in pain management: Oral fluid testing. Moore C J Opioid Manag; 2015; 11(1):69-75. PubMed ID: 25750167 [TBL] [Abstract][Full Text] [Related]
9. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA. Marin SJ; Keith L; Merrell M; McMillin GA J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463 [TBL] [Abstract][Full Text] [Related]
10. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations. Cone EJ; Presley L; Lehrer M; Seiter W; Smith M; Kardos KW; Fritch D; Salamone S; Niedbala RS J Anal Toxicol; 2002; 26(8):541-6. PubMed ID: 12501910 [TBL] [Abstract][Full Text] [Related]
11. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS). Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473 [TBL] [Abstract][Full Text] [Related]
12. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations. Truver MT; Palmquist KB; Swortwood MJ J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Drugs in Oral Fluid Using LC-MS/MS. Coulter CA; Moore CM Methods Mol Biol; 2019; 1872():237-259. PubMed ID: 30350295 [TBL] [Abstract][Full Text] [Related]
14. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France. Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427 [TBL] [Abstract][Full Text] [Related]
15. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood. Gjerde H; Langel K; Favretto D; Verstraete AG Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911 [TBL] [Abstract][Full Text] [Related]
16. Utility of oral fluid in compliance monitoring of opioid medications. Conermann T; Gosalia AR; Kabazie AJ; Moore C; Miller K; Fetsch M; Irvan D Pain Physician; 2014; 17(1):63-70. PubMed ID: 24452646 [TBL] [Abstract][Full Text] [Related]
17. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). Krotulski AJ; Mohr ALA; Friscia M; Logan BK J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050 [TBL] [Abstract][Full Text] [Related]
18. Drugs in oral fluid Part I. Validation of an analytical procedure for licit and illicit drugs in oral fluid. Wylie FM; Torrance H; Anderson RA; Oliver JS Forensic Sci Int; 2005 Jun; 150(2-3):191-8. PubMed ID: 15944059 [TBL] [Abstract][Full Text] [Related]
19. The frequency of alcohol, illicit and licit drug consumption in the general driving population in South-East Hungary. Institóris L; Tóth AR; Molnár A; Arok Z; Kereszty E; Varga T Forensic Sci Int; 2013 Jan; 224(1-3):37-43. PubMed ID: 23149316 [TBL] [Abstract][Full Text] [Related]
20. The prevalence of alcohol and drugs in sampled oral fluid is related to sample volume. Gjerde H; Normann PT; Christophersen AS J Anal Toxicol; 2010 Sep; 34(7):416-9. PubMed ID: 20822680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]